Skip to Main Content

Paper Details

Wild-type <i>TP53</i> defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs.
Am J Cancer Res
5
2019
GBM, GSCs, GSIs, Glioblastoma, NOTCH, NOTCH1, Wild-type TP53, doxorubicin, gamma-secretase, glioma, glioma sphere-forming cells, p53, patients, primary intracranial tumor, temozolomide, wild, wild-type TP53, wild-type TP53 (wt-p53) GSCs, wt, wt-, wt-p53
Author NameAffiliation
Dimpy KoulThe University of Texas MD Anderson Cancer Center Houston
Wai-Kwan Alfred YungThe University of Texas MD Anderson Cancer Center Houston
Wai-Kwan Alfred YungThe University of Texas MD Anderson Cancer Center Houston
  • 1 - 3

Datasets

Release 1.2